The Association of Flap Endonuclease 1 Genotypes with the Susceptibility of Endometriosis

Chou AK, An-Kuo Chou, An‐Kuo Chou, Ming-Yi Shen, Ming‐Yi Shen, Chen FY, Fang-Yu Chen, Hsiao CL, Chieh-Lun Hsiao, Shih LC, Liang-Chun Shih, Chang WS, Wen-Shin Chang, Tsai CW, Chia-Wen Tsai, Ying TH, Tsung-Ho Ying, MING-HSIEN WU, Wu MH, Chung-Yu Huang, Chung‐Yu Huang, Huang CY, DA-Tian Bau, Bau DT
Cancer genomics & proteomics · 2017 · vol. 14(6) , pp. 455–460 · doi:10.21873/cgp.20055 · PMID:29109095 · PMC6070328 · W2767703315
Observational OA: diamond CC0
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This study found that the FEN1 rs174538 A allele is a protective biomarker for endometriosis in a Taiwanese population, with interactions related to age of menarche and pregnancy status.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND/AIM: Flap endonuclease 1 (FEN1), a protein with multiple functions in genome stability maintenance, is important in cancer prevention. The two functional germline variants of FEN1, rs174538 and rs4246215, regarding cancer susceptibility have been reported in lung, breast, liver, esophageal, gastric, colorectal cancer, glioma and leukemia, but not endometriosis. In this study, we firstly aimed at evaluating the contribution of FEN1 genotypes to endometriosis risk in a representative Taiwan population. MATERIALS AND METHODS: In total, 153 patients with endometriosis and 636 non-cancer healthy controls were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) methodology. RESULTS: The genotypes of FEN1 rs174538, but not those of rs4246215, were differently distributed between the endometriosis and control groups. In detail, the AA of FEN1 rs174538 genotypes were significantly less frequently found among endometriosis patients than among controls (odds ratio [OR]=0.43, 95% confidence interval [CI]=0.24-0.78, p=0.0125). The A allele at FEN1 rs174538 was also significantly less frequent among cases than controls (OR=0.65, 95%CI=0.50-0.86, p=0.0021). As for age of first menarche, those with first menarche at the age >12.8 carrying the FEN1 rs174538 AA genotype conferred lower OR of 0.29 (95%CI=0.11-0.78, p=0.0381) for endometriosis. Regarding the full pregnancy status, those without having had a full-term pregnancy carrying the FEN1 rs174538 AA genotype were of lower risk (ORs=0.12, 95%CI=0.03-0.53, p=0.0050). CONCLUSION: The FEN1 rs174538 A allele is a novel protective biomarker for endometriosis and this genotype may have interactions with age- and hormone-related factors on the development of endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Flap Endonucleases Adult Adult Endometriosis Endometriosis Endometriosis Female Female Flap Endonucleases Flap Endonucleases Genetic Predisposition to Disease Genetic Predisposition to Disease Genotype Genotype Humans Humans Male Male

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (32)

SciLite annotations

chemicals 4
alcohol steroid estrogen testosterone
organisms 2
rodents human

Source provenance

europepmc
last seen: 2026-10-16T06:09:50.462052+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:20:50.926721+00:00
scilite
last seen: 2026-05-18T04:25:29.313245+00:00
License: CC0 · commercial use OK